US 7,485,327 B2
	Composition comprising Melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
Min-Young Kim, Taejon (Korea, Republic of); Byung-Young Park, Taejon (Korea, Republic of); Chang-Hee Moon, Taejon (Korea, Republic of); Eun-Kyu Park, Taejon (Korea, Republic of); and Kyoung-Mi Kim, Jeonju (Korea, Republic of)
Assigned to AngioLab, Inc., Daejeon (Korea, Republic of)
Filed on Jun. 12, 2003, as Appl. No. 10/460,951.
Application 10/460951 is a continuation in part of application No. PCT/KR01/02148, filed on Dec. 12, 2001.
Prior Publication US 2004/0009244 A1, Jan. 15, 2004
Int. Cl. A61K 36/00 (2006.01)

U.S. Cl. 424—774  [424/725]

4 Claims

1. A method of inhibiting angiogenesis and an angiogenesis associated disease, comprising administering an angiogenesis inhibiting effective amount of a composition comprising Melissa leaf extract to a subject suffering from said angiogenesis associated disease, wherein the Melissa leaf extract is administered in an amount of from about 5 mg to about 2000 mg per day.